WuXi PharmaTech Inc. (WX)

[surf1944]

2:04AM WuXi PharmaTech enters into collaboration with Johnson & Johnson Pharmaceutical R&D, a division of Janssen Pharmaceutica for preclinical services and training (WX) 16.14 : Co announces it has reached an agreement with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica N.V., to collaborate in the area of preclinical services. Under the agreement, WuXi PharmaTech will become a provider of toxicology and other non-clinical services to JANSSEN. In addition, JANSSEN will provide training and other services, reimbursed by WuXi, to establish the GLP quality system and technical capabilities to meet the international standards at WuXi's toxicology facility in Suzhou, China